Ryo Ito

879 total citations
53 papers, 581 citations indexed

About

Ryo Ito is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Ryo Ito has authored 53 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Physiology and 11 papers in Oncology. Recurrent topics in Ryo Ito's work include Thermoregulation and physiological responses (8 papers), Exercise and Physiological Responses (6 papers) and Hormonal Regulation and Hypertension (5 papers). Ryo Ito is often cited by papers focused on Thermoregulation and physiological responses (8 papers), Exercise and Physiological Responses (6 papers) and Hormonal Regulation and Hypertension (5 papers). Ryo Ito collaborates with scholars based in Japan, United States and South Korea. Ryo Ito's co-authors include Atsushi Yokoyama, Shigeru Kigoshi, Akira Sugawara, Tomoko Okumura, Masashi Hada, Hikaru Tsuchiya, Koji Miyanishi, Kohichi Takada, Kazuyuki Murase and Masayoshi Kobune and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ryo Ito

43 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Ito Japan 12 308 112 88 62 61 53 581
Hiroko Mitsui Japan 15 249 0.8× 111 1.0× 61 0.7× 55 0.9× 40 0.7× 38 579
Liping Mao China 16 336 1.1× 109 1.0× 113 1.3× 77 1.2× 121 2.0× 74 752
Donglin Jiang China 13 434 1.4× 99 0.9× 72 0.8× 63 1.0× 148 2.4× 27 711
Xiao Ma China 18 424 1.4× 136 1.2× 122 1.4× 120 1.9× 97 1.6× 81 919
Noriko Satake United States 16 302 1.0× 72 0.6× 49 0.6× 59 1.0× 63 1.0× 42 763
Guirong Sun China 14 182 0.6× 131 1.2× 86 1.0× 61 1.0× 53 0.9× 32 587
Satoru Hosokawa Japan 12 142 0.5× 163 1.5× 52 0.6× 85 1.4× 66 1.1× 51 523
Ardeshir Abbasi Iran 15 240 0.8× 90 0.8× 24 0.3× 60 1.0× 71 1.2× 47 710

Countries citing papers authored by Ryo Ito

Since Specialization
Citations

This map shows the geographic impact of Ryo Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Ito more than expected).

Fields of papers citing papers by Ryo Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Ito. The network helps show where Ryo Ito may publish in the future.

Co-authorship network of co-authors of Ryo Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Ito. A scholar is included among the top collaborators of Ryo Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Ito. Ryo Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osuga, Takahiro, Koji Miyanishi, Ryo Ito, et al.. (2025). Hepatocellular Carcinoma Presenting with Pseudoprogression in a Patient Receiving Atezolizumab Plus Bevacizumab Combination Therapy. Internal Medicine. 64(14). 2148–2154.
2.
Ito, Ryo, Satoko Amemori, & Ken‐ichi Amemori. (2025). Predictive coding in the primate brain: From visual to fronto-limbic systems. Neuroscience Research. 221. 104972–104972.
5.
Matsumura, Yoshihiro, Timothy F. Osborne, Ryo Ito, Hiroki Takahashi, & Juro Sakai. (2024). β-Adrenergic Signal and Epigenomic Regulatory Process for Adaptive Thermogenesis. Advances in experimental medicine and biology. 1461. 213–227.
6.
Noguchi, Takuya, Ryo Ito, Aya Inoue, et al.. (2024). Aggregability of the SQSTM1/p62-based aggresome-like induced structures determines the sensitivity to parthanatos. Cell Death Discovery. 10(1). 74–74. 2 indexed citations
7.
Ito, Ryo, Koji Miyanishi, Tomohiro Kubo, et al.. (2023). Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma. Hepatology International. 17(3). 735–744. 11 indexed citations
8.
Heishima, Kazuki, Nobuhiko Sugito, Tomoyoshi Soga, et al.. (2021). Petasin potently inhibits mitochondrial complex I–based metabolism that supports tumor growth and metastasis. Journal of Clinical Investigation. 131(17). 22 indexed citations
9.
Sakamoto, Hiroki, Koji Miyanishi, Shingo Tanaka, et al.. (2021). MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model. Scientific Reports. 11(1). 3599–3599. 6 indexed citations
10.
Ito, Ryo, Naoyuki Yamashita, & Takaaki Matsumoto. (2018). Effects of arm insulation on physiological responses during running in the cold. The Journal of Sports Medicine and Physical Fitness. 58(9). 1197–1203. 1 indexed citations
11.
Ito, Ryo, Ikuko Sato, Tadayuki Tsujita, Atsushi Yokoyama, & Akira Sugawara. (2017). A ubiquitin-proteasome inhibitor bortezomib suppresses the expression of CYP11B2, a key enzyme of aldosterone synthesis. Biochemical and Biophysical Research Communications. 489(1). 21–28. 7 indexed citations
12.
Suzuki, Dai, Ryo Ito, Kyoko Shimizu, et al.. (2017). Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure. PLoS ONE. 12(8). e0181055–e0181055. 8 indexed citations
13.
Ito, Ryo, et al.. (2015). Hydroxylation of methylated DNA by TET1 in chondrocyte differentiation of C3H10T1/2 cells. SHILAP Revista de lepidopterología. 5. 134–140. 6 indexed citations
14.
Meguro, Shu, Masuomi Tomita, Takeshi Katsuki, et al.. (2014). Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus. International Journal of Endocrinology. 2014. 1–6. 15 indexed citations
15.
Yamashita, Naoyuki, Ryo Ito, Masataka Nakano, & Takaaki Matsumoto. (2014). Two Percent Hypohydration Does Not Impair Self-Selected High-Intensity Intermittent Exercise Performance. The Journal of Strength and Conditioning Research. 29(1). 116–125. 5 indexed citations
16.
Yokoyama, Atsushi, Katsuhide Igarashi, Tetsuya Sato, et al.. (2014). Identification of Myelin Transcription Factor 1 (MyT1) as a Subunit of the Neural Cell Type-specific Lysine-specific Demethylase 1 (LSD1) Complex. Journal of Biological Chemistry. 289(26). 18152–18162. 32 indexed citations
17.
Matsuda, Ken, Akira Uruno, Kaori Sugawara, et al.. (2013). Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells. Molecular and Cellular Endocrinology. 383(1-2). 60–68. 8 indexed citations
18.
Ito, Ryo, et al.. (2012). TATA-binding Protein (TBP)-like Protein Is Required for p53-dependent Transcriptional Activation of Upstream Promoter of p21 Gene. Journal of Biological Chemistry. 287(24). 19792–19803. 21 indexed citations
19.
Shibuya, Michiko, Ryo Ito, Ikue Taneike, et al.. (2003). Occurrence of a Vibrio vulnificus Infection in Niigata in 2003. 51(4). 149–156. 1 indexed citations
20.
Ohno, Masuo, et al.. (1998). Hypertension in Leigh Syndrome -A Case Report. Neuropediatrics. 29(5). 265–267. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026